Network origin in Tami Rachmilewitz first degree
Entity | Entity type | Industry | |
---|---|---|---|
Subsidiary | Biotechnology | 12 | |
Extinct | Biotechnology | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Tami Rachmilewitz via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Corporate Officer/Principal | |
ARQULE, INC. | Pharmaceuticals: Major | Director/Board Member | |
DYAX CORP. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
THE SUSTAINABLE NUTRITION GROUP LTD | Agricultural Commodities/Milling | Director/Board Member | |
OMRIX Biopharmaceuticals, Inc.
OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Pharmaceuticals: Major | Chairman Founder | |
ADMA BIOLOGICS, INC. | Biotechnology | Director/Board Member | |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Neuroptics, Inc.
Neuroptics, Inc. Medical SpecialtiesHealth Technology NeurOptics, Inc. provides neurological patient care services. It offers npi-100 pupillometer, an hand-held and cordless device that removes subjectivity in the measurement of pupil size and the pupillary light reflex. The company was founded by Kamran Siminou and is headquartered in Irvine, CA. | Medical Specialties | Chief Executive Officer | |
BLUEBIRD BIO, INC. | Biotechnology | Corporate Officer/Principal | |
Touro College | College/University | Undergraduate Degree | |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Technion-Israel Institute of Technology | College/University | Graduate Degree Graduate Degree | |
The Hebrew University of Jerusalem | College/University | Graduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
St. Lawrence University | College/University | Undergraduate Degree | |
Ben-Gurion University of the Negev | College/University | Doctorate Degree Doctorate Degree | |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bristol-Myers Squibb World Wide Medicines Group
Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb World Wide Medicines Group manufactures pharmaceutical products. The company is based in Lawrenceville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bristol-Myers Squibb Pharmaceutical Research Institute | Corporate Officer/Principal | ||
Youdim Pharmaceuticals Ltd.
Youdim Pharmaceuticals Ltd. Investment ManagersFinance Youdim Pharmaceuticals Ltd (Youdim Pharmaceuticals) is a venture capital subsidiary of XT Investments Ltd founded in 1997. The firm is headquartered in Yokneam, Israel. | Investment Managers | Chief Executive Officer | |
Clal Life Sciences (CLS) LP
Clal Life Sciences (CLS) LP Investment ManagersFinance Part of Clal Biotechnology Industries Ltd., Clal Life Sciences (CLS) LP is a venture capital fund. | Investment Managers | Corporate Officer/Principal | |
IMMUNE DESIGN CORP | Pharmaceuticals: Major | Director/Board Member | |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
Bristol-Myers Squibb Australia Pty Ltd.
Bristol-Myers Squibb Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Australia Pty Ltd. is a biopharmaceutical company that researches, develops and markets medicines for serious diseases. The company was founded in 1930 and is headquartered in Noble Park North, Australia. | Pharmaceuticals: Major | Chief Executive Officer | |
The College of Management Academic Studies | College/University | Graduate Degree | |
COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Sales & Marketing Chief Tech/Sci/R&D Officer | |
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Medicines Australia is a non-profit organization which designs, develops, and implements health and industry policies for pharmaceutical industry. It builds and maintains relationships with government for fair reimbursement of medicines to ensure the continuation of a viable medicines industry, administers the Medicines Australia Code of Conduct which sets the standard for the ethical marketing and promotion of prescription medicines, and provides specialist advice to member companies. The organization is headquartered in Deakin, Australia. | Pharmaceuticals: Major | Director/Board Member | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
Universitat Autònoma de Barcelona | College/University | Doctorate Degree | |
Regenerative Medicine Foundation
Regenerative Medicine Foundation Medical SpecialtiesHealth Technology The Regenerative Medicine Foundation is a non-profit organization that aims to accelerate the development of regenerative medicine to improve health and deliver cures. The non-profit company is based in Winston-Salem, NC. The foundation fosters strategic collaborations to achieve its mission and produces its flagship event, the World Stem Cell Summit. Additionally, the foundation honors leaders in the field through the Stem Cell and Regenerative Medicine Action Awards and promotes educational initiatives. | Medical Specialties | Director/Board Member | |
The Fuqua School of Business | College/University | Masters Business Admin | |
Yale School of Medicine | College/University | Corporate Officer/Principal | |
Duke University School of Medicine | College/University | Doctorate Degree | |
DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
DepYmed, Inc.
DepYmed, Inc. BiotechnologyHealth Technology DepYmed , Inc. is a cancer and rare disease therapeutic development company. The company is headquartered in Farmingdale, NY. | Biotechnology | Founder | |
DARÉ BIOSCIENCE, INC. | Pharmaceuticals: Major | Director/Board Member | |
DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Miscellaneous Commercial Services | Director/Board Member | |
LIVEKIDNEY.BIO
LIVEKIDNEY.BIO Miscellaneous Commercial ServicesCommercial Services Kidneycure Ltd. develops cell therapies to prevent progression of chronic kidney diseases. The company was founded by Benjamin and Dekel Orit Harari-Steinberg and is headquartered in Tel Aviv, Israel. | Miscellaneous Commercial Services | Chief Executive Officer | |
NEUBASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Orphion Therapeutics, Inc.
Orphion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orphion Therapeutics, Inc. develops novel gene therapies for the treatment of genetic disorders. The private company is based in Great Neck, NY. The company was founded by Samuel I. Backenroth. The CEO is Jason Scott Slakter. | Pharmaceuticals: Major | Founder | |
MATRICELF LTD | Biotechnology | Director/Board Member |
Statistics
International
United States | 31 |
Israel | 13 |
Australia | 4 |
Germany | 3 |
United Kingdom | 2 |
Sectoral
Health Technology | 32 |
Consumer Services | 12 |
Finance | 3 |
Commercial Services | 3 |
Process Industries | 2 |
Operational
Director/Board Member | 113 |
Corporate Officer/Principal | 55 |
Independent Dir/Board Member | 43 |
Founder | 17 |
Undergraduate Degree | 16 |
Most connected contacts
Insiders | |
---|---|
Michael Rice | 33 |
Robert Taub | 27 |
Marc Kozin | 24 |
Ben Shapiro | 24 |
Susan Kelley | 22 |
Larry Ellberger | 16 |
Ruth Arnon | 15 |
Ronald Cohen | 11 |
Alison Finger | 11 |
Alon Yaar | 8 |
Samuel Backenroth | 8 |
Shmuel Ben Zvi | 8 |
Oron Yacoby-Zeevi | 7 |
Michal Roytman | 5 |
Matthew Trudeau | 4 |
- Stock Market
- Insiders
- Tami Rachmilewitz
- Company connections